Abstract

The summary of product characteristics from the European Medicines Agency is a reference document on medicines in the EU. It contains textual information for clinical experts on how to safely use medicines, including adverse drug reactions. Using natural language processing (NLP) techniques to automatically extract adverse drug reactions from such unstructured textual information helps clinical experts to effectively and efficiently use them in daily practices. Such techniques have been developed for Structured Product Labels from the Food and Drug Administration (FDA), but there is no research focusing on extracting from the Summary of Product Characteristics. In this work, we built a natural language processing pipeline that automatically scrapes the summary of product characteristics online and then extracts adverse drug reactions from them. Besides, we have made the method and its output publicly available so that it can be reused and further evaluated in clinical practices. In total, we extracted 32,797 common adverse drug reactions for 647 common medicines scraped from the Electronic Medicines Compendium. A manual review of 37 commonly used medicines has indicated a good performance, with a recall and precision of 0.99 and 0.934, respectively.

Highlights

  • Drug product labels are regulatory documents required as part of the marketing authorization of each medicine

  • Using natural language processing (NLP) techniques to automatically extract adverse drug reactions from such unstructured textual information helps clinical experts to effectively and efficiently use them in daily practices. Such techniques have been developed for Structured Product Labels from the Food and Drug Administration (FDA), but there is no research focusing on extracting from the Summary of Product Characteristics

  • We built a natural language processing pipeline that automatically scrapes the summary of product characteristics online and extracts adverse drug reactions from them

Read more

Summary

Introduction

Drug product labels are regulatory documents required as part of the marketing authorization of each medicine. They provide up-to-date and comprehensive information about the risks, benefits, and pharmacological properties of marketed medicines. During post-marketing safety assessments, it is crucial to determine whether an investigated adverse drug reaction (ADR) is already labeled [1,2]. Agency (EMA) in the EU [3] Both product labels provide information in sections, and the content of each section is in free narrative texts. This study focuses on the undesirable side effect section of product labels which describes adverse drug reactions (ADRs)

Methods
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.